Josh Makower, director and co-founder of the Stanford Byers Center for Biodesign, explains his approach to the ethics of fair profit in medical innovation, observing that a profitable business creates a return for investors, who can then reinvest in future innovation.

Video clips from: The Biodesign Innovation Process [Entire Talk]

2 minutes

What is the Biodesign Process?

Watch now

3 minutes

Success and Failure in the Biodesign Process

Watch now

3 minutes

Solutions for Rare Conditions

Watch now

2 minutes

Innovating for Health Equity

Watch now

2 minutes

Medical Innovation and Profit

Watch now

Share Post